A Study of Armored CAR T Cells in People With Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to test the safety of DLL3-SAVVYZ-IL18 in people with DLL3+ cancer.
Epistemonikos ID: ac7dc35f18076642f4a4cb0d7b84cf8613895fcd
First added on: Aug 26, 2026